KRAS and colorectal carcinoma: HCT116 cells also harbour a mutation in KRAS, which activates the ERK MAP kinase signalling cascade downstream of growth factor receptors and has been implicated in regulating the proteome of CRC cell exosomes (Demory Beckler et al, 2013).